EGFR mutation conferring primary resistance to gefitinib in non-small-cell lung cancer

被引：142

作者：

Shih, JY ^{[1
]}

Gow, CH ^{[1
]}

Yang, PC ^{[1
]}

机构：

[1] Natl Taiwan Univ Hosp, Taipei 100, Taiwan

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2005年 / 353卷 / 02期

关键词：

D O I：

10.1056/NEJM200507143530217

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：207 / 208

页数：2

共 5 条

[1] EGFR mutation and resistance of non-small-cell lung cancer to gefitinib [J].

Kobayashi, S ;

Boggon, TJ ;

Dayaram, T ;

Janne, PA ;

Kocher, O ;

Meyerson, M ;

Johnson, BE ;

Eck, MJ ;

Tenen, DG ;

Halmos, B .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (08) :786-792

[2] Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].

Lynch, TJ ;

Bell, DW ;

Sordella, R ;

Gurubhagavatula, S ;

Okimoto, RA ;

Brannigan, BW ;

Harris, PL ;

Haserlat, SM ;

Supko, JG ;

Haluska, FG ;

Louis, DN ;

Christiani, DC ;

Settleman, J ;

Haber, DA .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139

[3] EGFR mutations in non-small-cell lung cancer:: Analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment [J].

Marchetti, A ;

Martella, C ;

Felicioni, L ;

Barassi, F ;

Salvatore, S ;

Chella, A ;

Camplese, PP ;

Iarussi, T ;

Mucilli, F ;

Mezzetti, A ;

Cuccurullo, F ;

Sacco, R ;

Buttitta, F .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) :857-865

[4] Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain [J].

Pao, W ;

Miller, VA ;

Politi, KA ;

Riely, GJ ;

Somwar, R ;

Zakowski, MF ;

Kris, MG ;

Varmus, H .

PLOS MEDICINE, 2005, 2 (03) :225-235

[5] Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways [J].

Sordella, R ;

Bell, DW ;

Haber, DA ;

Settleman, J .

SCIENCE, 2004, 305 (5687) :1163-1167

← 1 →